Cardiovascular and Pulmonary Impact of the Ebola Virus: A Review of Current Literature and Practices

BOLA VIRUS DISEASE (EVD), caused by infection with the filovirus Zaire ebolavirus, has a wide range of cardiovascular and pulmonary effects. The disease was first observed in 1976 in the Ebola River valley in what is now the Democratic Republic of the Congo, Africa. 1 Since then, Zaire ebolavirus has caused a number of outbreaks over the past 3 decades 2 (Table 1) and has culminated in the current largest outbreak, which has spanned a number of West African countries and spread throughout the world (Table 2). 3